Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents
β Scribed by Pamela E. Hendershot; Joseph C. Fleishaker; Keh-Ming Lin; Inocencia D. Nuccio; Russell E. Poland
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 55 KB
- Volume
- 155
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The pharmacokinetics of reboxetine, a new antidepressant agent, were found to be close to linear in a crossover study comparing administration of single 2, 3, 4 and 5 mg capsule doses in 15 healthy male volunteers, and in the same study the capsules were bioequivalent to the proposed th
The pharmacokinetics of reboxetine have been investigated in 12 healthy male volunteers after a single 2mg dose of reboxetine and at steady state, following the last administration of a multiple-dose regimen (2mg twice a day for 54d). Reboxetine was analysed in plasma and urine samples collected up
Objectives: To determine the effect of reduced hepatic function on the pharmacokinetics of minoxidil. The pharmacokinetics of antipyrine, lorazepam, and indocyanine green were included as indicators of hepatic function. Methods: Eight mild cirrhotics and eight healthy subjects received antipyrine (p